Valvulopatía mitral y tricuspídea

Mitral valve disease epidemiology and treatment have changed significantly in recent years. Mitral valve insufficiency is the second leading cause of valvulopathy in the Western world. The most common etiologies are degenerative and ischemic disease. In the Western world, mitral stenosis has become less common and the most cases are rheumatic in origin. Echocardiogram is imaging technique of choice in the diagnosis and follow-up of both entities. Surgery remains the most common treatment modality for mitral valve disease although there has been an increasing trend towards mitral valve repair. Percutaneous mitral valvuloplasty continues playing an important role in the management of subsidiary patients for receiving treatment. Percutaneous mitral valve repair using the MitraClip system has been developed although currently its indications are very restricted.